(Q42278661)

English

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

scientific article published on April 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Goldberg AI

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dunlay MC

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sweet CS

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

1 April 1995

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

793-795

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Pharmacology of Nonpeptide Angiotensin II Receptor Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980413-5

7 January 2021

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980413-5

7 January 2021

Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980413-5

7 January 2021

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980413-5

7 January 2021

Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist, in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980413-5

7 January 2021

Identifiers

10.1016/S0002-9149(99)80413-5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42278661&oldid=2146471248"